Product Program year 2020 Source: CMS Open Payments

Cellex/Xts Photopheresis System

Device Critical Care

Open in the dashboard

General payments

$368,097

326 payments

Research payments

$5,682,285

3 payments

Through program year 2020, $368,097 in general payments and $5,682,285 in research payments were reported against Cellex/Xts Photopheresis System (Critical Care).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $112,355 96
2020 Research $3,149,760 1
2019 General $255,742 230
2019 Research $2,532,525 2

Breakdown

Who paid General payments · program years 2019–2020
  1. Mallinckrodt Enterprises LLC $255,742 230 payments
  2. Mallinckrodt Hospital Products Inc. $112,355 96 payments
Top recipients General payments · program year 2020
  1. Madan Jagasia Hematology & Oncology · Nashville, TN $29,768 26% · 13 payments
  2. John Koreth Hematology & Oncology · Boston, MA $17,770 16% · 10 payments
  3. Miguel Perales Medical Oncology · New York, NY $17,073 15% · 10 payments
  4. Uc Davis Medical Center Teaching hospital · CA $7,000 6% · 7 payments
  5. Morristown Medical Center Teaching hospital · NJ $5,000 4% · 5 payments

The top 5 of 25 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Hematology & Oncology Internal Medicine $53,672 66% · 10 practitioners
  2. Medical Oncology Internal Medicine $17,073 21% · 1 practitioner
  3. Dermatology $7,183 9% · 3 practitioners
  4. Hematology Internal Medicine $3,150 4% · 1 practitioner
  5. Clinical Pathology/Laboratory Medicine Pathology $250 <1% · 2 practitioners

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Tennessee $32,778 29% · 2 recipients
  2. New York $24,979 22% · 3 recipients
  3. Massachusetts $17,770 16% · 1 recipient
  4. California $7,169 6% · 9 recipients
  5. Texas $7,000 6% · 2 recipients

The top 5 of 12 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

326 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record